The Relationship Between Small Dense Low-Density Lipoprotein Cholesterol and Metabolic Syndrome

References

• Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375(9710):181–183. doi:10.1016/S0140-6736(09)61794-3
   PubMed Web of Science ®Google Scholar
• Mendrick DL, Diehl AM, Topor LS, et al. Metabolic syndrome and associated diseases: from the bench to the clinic. Toxicol Sci. 2018;162:36–42. doi:10.1093/toxsci/kfx233
   PubMed Web of Science ®Google Scholar
• Masrouri S, Moazzeni SS, Cheraghloo N, Azizi F, Hadaegh F. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: two decades of follow-up from the Tehran lipid and glucose study. Cardiovasc Diabetol. 2022;21:269. doi:10.1186/s12933-022-01707-1
   PubMed Web of Science ®Google Scholar
• Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones. 2018;17:299–313. doi:10.1007/s42000-018-0051-3
   PubMedGoogle Scholar
• Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313:1973–1974. doi:10.1001/jama.2015.4260
   PubMed Web of Science ®Google Scholar
• Taghizadeh S, Alizadeh M. The role of lipids in the pathogenesis of metabolic syndrome in adolescents. Exp Clin Endocrinol Diabetes. 2018;126:14–22. doi:10.1055/s-0043-106439
   PubMed Web of Science ®Google Scholar
• Kim JE, Kim JS, Jo MJ, et al. The roles and associated mechanisms of adipokines in development of metabolic syndrome. Molecules. 2022;27:1.
   Web of Science ®Google Scholar
• Towfighi A, Ovbiagele B. Metabolic syndrome and stroke. Curr Diab Rep. 2008;8:37–41. doi:10.1007/s11892-008-0008-z
   PubMed Web of Science ®Google Scholar
• Dziegielewska-Gesiak S, Muc-Wierzgon M. Inflammation and oxidative stress in frailty and metabolic syndromes-two sides of the same coin. Metabolites. 2023;13. doi:10.3390/metabo13040475
   PubMed Web of Science ®Google Scholar
• Dziegielewska-Gesiak S, Wyszomirska K, Fatyga E, Wysocka E, Muc-Wierzgon M. The role of oxidant-antioxidant markers and resistin in metabolic syndrome elderly individuals. Sci Prog. 2021;104(2):368504211006510. doi:10.1177/00368504211006510
   PubMedGoogle Scholar
• Adiels M, Olofsson SO, Taskinen MR, Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225–1236. doi:10.1161/ATVBAHA.107.160192
   PubMed Web of Science ®Google Scholar
• Nikolic D, Katsiki N, Montalto G, Isenovic ER, Mikhailidis DP, Rizzo M. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients. 2013;5:928–948. doi:10.3390/nu5030928
   PubMed Web of Science ®Google Scholar
• Cho Y, Lee SG, Jee SH, Kim JH. Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome. Ann Lab Med. 2015;35:586–594. doi:10.3343/alm.2015.35.6.586
   PubMed Web of Science ®Google Scholar
• Fan J, Liu Y, Yin S, et al. Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation. Nutr Metab. 2019;16. doi:10.1186/s12986-019-0334-y
   Google Scholar
• Liou L, Kaptoge S. Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: a systematic review and meta-analysis. PLoS One. 2020;15:e0241993. doi:10.1371/journal.pone.0241993
   PubMed Web of Science ®Google Scholar
• Jin X, Yang S, Lu J, Wu MS. Dense low-density lipoprotein-cholesterol and atherosclerosis: relationship and therapeutic strategies. Front Cardiovasc Med. 2021;8:804214. doi:10.3389/fcvm.2021.804214
   PubMed Web of Science ®Google Scholar
• Huang J, Gu JX, Bao HZ, et al. Elevated serum small dense low-density lipoprotein cholesterol may increase the risk and severity of coronary heart disease and predict cardiovascular events in patients with type 2 diabetes mellitus. Dis Markers. 2021;2021:5597028. doi:10.1155/2021/5597028
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program Expert Panel on Detection, E. Treatment of high blood cholesterol in, A. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation. 2002;106:3143–3421. doi:10.1161/circ.106.25.3143
   PubMed Web of Science ®Google Scholar
• Hirano T, Nohtomi K, Sato Y, Kamata K, Ito Y. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia. Atherosclerosis. 2009;205:603–607. doi:10.1016/j.atherosclerosis.2009.01.009
   PubMed Web of Science ®Google Scholar
• Santos HO, Earnest CP, Tinsley GM, Izidoro LFM, Macedo RCO. Small dense low-density lipoprotein-cholesterol (sdLDL-C): analysis, effects on cardiovascular endpoints and dietary strategies. Prog Cardiovasc Dis. 2020;63:503–509. doi:10.1016/j.pcad.2020.04.009
   PubMed Web of Science ®Google Scholar
• Satoh N, Wada H, Ono K, et al. Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome. Circ J. 2008;72:932–939. doi:10.1253/circj.72.932
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ke Y, Hong H. HDL and Lipid Metabolism. Adv Exp Med Biol. 2022;1377:49–61.
   PubMedGoogle Scholar
• Hovingh GK, Rader DJ, Hegele RA. HDL re-examined. Curr Opin Lipidol. 2015;26:127–132. doi:10.1097/MOL.0000000000000161
   PubMed Web of Science ®Google Scholar
• Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol. 2013;18:53–56.
   PubMedGoogle Scholar
• Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263–355. doi:10.1080/20014091084227
   PubMed Web of Science ®Google Scholar
• Neuman MG, Malnick S, Chertin L. Gamma glutamyl transferase - an underestimated marker for cardiovascular disease and the metabolic syndrome. J Pharm Pharm Sci. 2020;23:65–74. doi:10.18433/jpps30923
   PubMed Web of Science ®Google Scholar
• Liu CF, Zhou WN, Fang NY. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies. Int J Clin Pract. 2012;66:692–698. doi:10.1111/j.1742-1241.2012.02959.x
   PubMed Web of Science ®Google Scholar
• Qin X, Qiu L, Tang G, et al. Prevalence of metabolic syndrome among ethnic groups in China. BMC Public Health. 2020;20:297. doi:10.1186/s12889-020-8393-6
   PubMed Web of Science ®Google Scholar
• He Y, Li Y, Bai G, et al. Prevalence of metabolic syndrome and individual metabolic abnormalities in China, 2002–2012. Asia Pac J Clin Nutr. 2019;28:621–633. doi:10.6133/apjcn.201909_28(3).0023
   PubMed Web of Science ®Google Scholar